Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT

Recruiting now

Conditions studied: Tuberculosis (TB), End-Stage Kidney Disease

In brief

This is an observational study among approximately 160 end-stage renal disease patients on renal replacement therapy and post-living donor or deceased donor kidney transplant recipients. Investigators aim to assess the proportion of positive IGRA associated with symptom development, sputum Xpert MTB/RIF assay, and chest radiograph to define latent TB infection and subclinical TB among ESKD and renal transplant patients.

Key facts

Study ID

NCT06700876

Run by

Mahidol University

People needed

160

Starts

2024-08-06

Expected to finish

2027-06-30

Last updated by the study team

2024-11-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• End-stage renal disease on renal replacement therapy (hemodialysis or peritoneal dialysis) or status-post-living donor or deceased donor kidney transplantation
• Aged more than or equal 18 years

You may not qualify if…

• Positive PPD test or a previously documented positive PPD
• Active pulmonary or extrapulmonary tuberculosis

Where it is running

• Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University — Bangkok, Thailand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.